ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0316

Relationship of Sensitization to Pain Severity in Patients with Knee Osteoarthritis

Lindsey MacFarlane1, Hanna Mass1, Catherine Yang1, Jose Acosta Julbe1, Antonia Chen1, Jeffrey Lange1, Morgan Jones1, Faith Selzer1, Jamie Collins1, Elena Losina2 and Jeffrey Katz1, 1Brigham and Women's Hospital, Boston, MA, 2Brigham and Women's Hospital, Boston, MA

Meeting: ACR Convergence 2023

Keywords: Osteoarthritis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0308–0324) Osteoarthritis – Clinical Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Pain in knee osteoarthritis (OA) is multifactorial and influenced by factors including pain sensitization. Most literature on sensitization and OA has contrasted persons with and without OA. We examined the association between knee pain severity and sensitization in a cohort of persons with OA. Further, within individuals with discordant knee pain, we compared sensitization between knees.

Methods: We recruited patients with knee OA from an orthopedic practice. Knee pain was assessed in each knee using the Knee Injury and Osteoarthritis Outcome Score (KOOS 0-100, 100 best) and categorized into tertiles; higher (< 47 points), moderate (³47 points and < 69), and lower (³ 69 points). We considered individuals to have ‘discordant pain’ if one knee was in the highest tertile and the other in the lowest. Participants underwent quantitative sensory testing (QST) including pain pressure threshold (PPT), temporal summation (TS), and conditioned pain modulation (CPM). We measured PPT at each knee and one wrist. We assessed TS at each knee and 3rd digit. We calculated CPM efficiency as the ratio of mean PPT testing at the wrist before and after the conditioning stimulus (PPT post/PPT pre). Higher TS scores and lower PPT and CPM indicate greater sensitization. We assessed PPT and TS at the knee in knee level analyses and CPM, PPT at the wrist and TS at the digit in person level analyses.

We investigated the relationship between knee pain and sensitization in knee-level and person-level analyses. In person level analyses, we classified individuals into pain tertiles of their most painful knee and examined differences across persons in CPM efficiency, TM at the 3rd digit, and PPT of the wrist. We assessed differences in sensitization between knee pain tertiles using ANOVA. In knee level analyses, we used linear mixed effect models to account for within person correlations. We used paired t-tests to compare differences in QST between discordant knees within an individual.

Results: The sample included 194 knees from 97 participants. Participants had a mean age of 64 years (SD 11), BMI of 30 (SD 8), and 63 (72%) were female. In person level analyses, we observed differences in TS at the 3rd digit across the pain severity tertiles with TS of 1.5 (SD 1.4) in the higher pain group vs 0.3 (SD 0.8) in the lower. We observed small (< 0.5 SD) person level differences across pain tertiles in PPT of the wrist and CPM (Table). In knee level analyses, we observed PPT at the knee increased modestly across pain tertiles. Among the 21 individuals with discordant knee pain, the more painful knee demonstrated modestly lower PPT at the knee (differences < 0.5 SD).

Conclusion: These data support prior research demonstrating greater sensitization in persons with greater knee pain. Our design permitted investigation of sensitization at the knee level. While knees with more pain (across persons and within person), generally had greater sensitization than knees with less pain, the magnitude of these differences was small. The limited influence of sensitization on knee pain in these cross-sectional analyses suggests investigators should have modest expectations of the efficacy of treatments targeting sensitization.

Supporting image 1

Sensitization in differing pain levels

Supporting image 2

Peripheral sensitization between knees in individuals with discordant levels of pain


Disclosures: L. MacFarlane: None; H. Mass: None; C. Yang: None; J. Acosta Julbe: None; A. Chen: Adaptive Phage Therapeutics, 2, 5, Avanos, 2, BICMD, 2, Convatec, 2, Elute, 5, Ethicon, 2, GLG, 2, Guidepoint, 2, Heraeus, 2, Hyalex, 11, IlluminOss, 11, IrriMax, 2, Osteal Therapeutics, 2, 11, Peptilogics, 2, 11, Pfizer, 2, Smith and Nephew, 2, Sonoran, 11, Stryker, 2, 9; J. Lange: Aesulap, 2, OnPoint Kneee, 4; M. Jones: Biosplice, 1, 2, Pacira, 5, Regeneron, 1, 2; F. Selzer: None; J. Collins: None; E. Losina: None; J. Katz: Biosplice, 5.

To cite this abstract in AMA style:

MacFarlane L, Mass H, Yang C, Acosta Julbe J, Chen A, Lange J, Jones M, Selzer F, Collins J, Losina E, Katz J. Relationship of Sensitization to Pain Severity in Patients with Knee Osteoarthritis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/relationship-of-sensitization-to-pain-severity-in-patients-with-knee-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/relationship-of-sensitization-to-pain-severity-in-patients-with-knee-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology